• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Sep 13, 2005; 102(37): 13052–13057.
Published online Sep 2, 2005. doi:  10.1073/pnas.0503900102
PMCID: PMC1201587

Targeting of the FYVE domain to endosomal membranes is regulated by a histidine switch


Specific recognition of phosphatidylinositol 3-phosphate [PtdIns(3)P] by the FYVE domain targets cytosolic proteins to endosomal membranes during key signaling and trafficking events within eukaryotic cells. Here, we show that this membrane targeting is regulated by the acidic cellular environment. Lowering the cytosolic pH enhances PtdIns(3)P affinity of the FYVE domain, reinforcing the anchoring of early endosome antigen 1 (EEA1) to endosomal membranes. Reversibly, increasing the pH disrupts phosphoinositide binding and leads to cytoplasmic redistribution of EEA1. pH dependency is due to a pair of conserved His residues, the successive protonation of which is required for PtdIns(3)P head group recognition as revealed by NMR. Substitution of the His residues abolishes PtdIns(3)P binding by the FYVE domain in vitro and in vivo. Another PtdIns(3)P-binding module, the PX domain of Vam7 and p40phox is shown to be pH-independent. This provides the fundamental functional distinction between the two phosphoinositide-recognizing domains. The presented mode of FYVE regulation establishes the unique function of FYVE proteins as low pH sensors of PtdIns(3)P and reveals the critical role of the histidine switch in targeting of these proteins to endosomal membranes.

Keywords: phosphoinositide, early endosome antigen 1

The specific recruitment of FYVE proteins to endosomes, multivesicular bodies, and phagosomes is primarily mediated by FYVE domain binding to membrane-embedded phosphatidylinositol 3-phosphate [PtdIns(3)P] (13). Additional membrane anchoring is provided by hydrophobic insertion into the bilayer, electrostatic interactions with acidic lipids (4, 5), and dimerization (6, 7). These synergistic factors are thought to be largely responsible for directing FYVE proteins to PtdIns(3)P-enriched membranes. Yet, the current model of FYVE domain function has several limitations and is not predictive. Some FYVE proteins localize inexplicably to sites that contain little PtdIns(3)P, such as the Golgi and endoplasmic reticulum (8, 9). On the other hand, places with significant PtdIns(3)P concentrations, such as the nucleus and mitochondria (10), do not appear to attract FYVE proteins. All canonical FYVE domains have been found to target PtdIns(3)P (refs. 6, 1016); however, their binding properties were investigated at pH values of 6.5–8.0, leading to a discrepancy in estimated affinities despite the highly conserved sequences and structures of the FYVE proteins.

The FYVE domain is defined by the three conserved elements: the N-terminal WxxD, the central RR/KHHCR, and the C-terminal RVC motifs that form the PtdIns(3)P binding site seen in the solution and crystal structures of early endosome antigen 1 (EEA1), Hrs, and Vps27p FYVE (6, 13, 17, 18). The PtdIns(3)P headgroup is coordinated by a cluster of four Arg/Lys and two His residues and the N-terminal Asp. Among them, the two adjacent His residues are the most conserved in the FYVE domain sequences. In this work, we demonstrate that anchoring of the FYVE domain to PtdIns(3)P-enriched membranes is strongly pH-dependent, being enhanced by the acidic cytosolic environment, and is regulated by a histidine switch. The presented mode of FYVE regulation differentiates this module from other phosphoinositide-binding domains and establishes its unique function as low pH sensor of PtdIns(3)P.

Materials and Methods

Mutagenesis and Protein Expression and Purification. See Supporting Text, which is published as supporting information on the PNAS web site.

NMR Spectroscopy and pH Titration. NMR spectra were recorded at 25°C on Varian INOVA 500 and 600 MHz spectrometers. The 1H-15N heteronuclear single quantum coherence (HSQC) spectra of 0.1–0.2 mM uniformly 15N-labeled wild-type or mutant EEA1 FYVE domain or Vam7 PX domain containing 0–5 mM C4-PtdIns(3)P (Echelon, Salt Lake City) were collected while pH of the samples was varied between 5.5 and 8.5. The normalized chemical-shift change was defined as [(ΔδH)2+(ΔδN/5)2]0.5, where ΔδH and ΔδN are 1H and 15N chemical shift changes in parts per million (19).

Calculations of pKa Values, Estimation of the Lipid-Binding Affinities, and Liposome Binding. See Supporting Text for details.

In Vivo Localization of EEA1 FYVE and p40phox PX Domains Fused with Enhanced Cyan Fluorescent Protein (ECFP) and EGFP. The ECFP-EEA1 FYVE domain-containing mammalian plasmid was generated by using pEYFP-FYVE as a template (provided by A. Sorkin, University of Colorado Health Sciences Center). The His1371Asn mutation in EGFP-FYVE construct (pEGFP-FYVE-His1371Asn) was introduced by using a QuikChange kit (Stratagene). The pEGFP p40phox PX construct was provided by W. Cho, Univ. of Illinois, Chicago. The HeLa cells were grown in DMEM (Invitrogen) supplied with 10% FBS (Sigma). The cells were transfected with pECFP-FYVE, pEGFP-FYVE-His1371Asn, or pEGFP-p40phox PX by using Effectene reagent (Qiagen, Valencia, CA) and 24 h later were replated onto 25 mm glass coverslips. Microscopic imaging of cells was performed 72 h after transfection. Before imaging, cells were washed three times with PBS followed by addition of buffered solutions (pH 6.0–8.5) containing 10 μg/ml nigerecin (Sigma) and 10 μg/ml monensin (Sigma). The buffered solutions consisted of 120 mM KCl, 20 mM NaCl, 0.5 mM CaCl2, 0.5 mM MgSO4, and 25 mM one of the reagents such as Mes, 4-morpholinepropanesulfonic acid, citrate, or Hepes (Fisher Scientific). After pH equilibration for 15 min, living cells were visualized on an Axiovert 200M microscope (Zeiss) with standard ECFP and FITC filter sets (Chroma Technology, Brattleboro, VT). For apoptosis experiments, images of HeLa cells transfected with pECFP-FYVE were acquired in DMEM-containing FBS while incubated with or without 1 μM staurosporin (STS) (Sigma) for 1 h at 33°C. Quantification of fluorescence intensities was performed with slidebook software (Intelligent Imaging Innovations, Santa Monica, CA).

For in vivo localization of EGFP-fusion EEA1 FYVE proteins (wild-type, His1371Asn mutant, and His1372Asn mutant) in yeast cells, see Supporting Text.


PtdIns(3)P Binding by the FYVE Domain Is pH-Dependent. Substantial changes in the NMR spectra of PtdIns(3)P-bound FYVE domain were induced by varying the solution pH. The most pronounced perturbations of 1H and 15N resonances were observed in the pH range of 6.0–8.0 (Fig. 1A). Furthermore, these perturbations mirrored chemical shift changes seen in the ligand-free FYVE domain as soluble C4-PtdIns(3)P lipid was titrated in at a constant pH value of 6.8 (Fig. 1B). As the pH of the PtdIns(3)P-bound FYVE domain sample was progressively increased, all 1H-15N crosspeaks shifted toward their positions in the ligand-free protein. At pH values >8.0, the spectrum became identical to that of the unbound FYVE domain. On the other hand, lowering the pH resulted in chemical shift changes that converged on those of the ligand-saturated form of the protein (Fig. 1 A and B; and Fig. 6, which is published as supporting information on the PNAS web site). Consequently, the ligand-bound and free states of the FYVE domain appear to be stabilized by lowering and raising the pH, respectively.

Fig. 1.
pH modulates PtdIns(3)P binding. Superimposed 1H-15N HSQC spectra of the PtdIns(3)P-bound (A) and ligand-free (C) FYVE domains collected while pH of the samples was adjusted to values shown (Insets). (B) Superimposed 1H-15N HSQC spectra of PtdIns(3)P ...

The structural effects of pH modulation on the FYVE domain were evident by mapping the chemical shift changes onto the protein's surface. The amide resonances of the WxxD, RRHHCR, and RVC motifs involved in PtdIns(3)P coordination were substantially affected by the pH adjustments (Fig. 1D). These perturbations were similar in direction and magnitude to the changes observed during PtdIns(3)P titration, where amide resonances were perturbed due to progressive increase in ligand occupancy (Fig. 1 D and E).

The midpoint of pH dependency was estimated from titration curves corresponding to the amide 1H and 15N resonance changes in the complex upon varying the pH. The curves revealed a common inflection point at pH 7.4 (Fig. 7A, which is published as supporting information on the PNAS web site). This is indicative of a two-state process in which the free and PtdIns(3)P-bound populations of the FYVE domain are in balance at the average cytosolic pH levels. Thus, the FYVE domain is fully PtdIns(3)P-bound at pH values of 6.1 or less and is fully unligated when the pH >8.0.

To determine the intrinsic effect of pH on the FYVE domain, the ligand-free protein was examined at different pH values. Only small perturbations in 1H and 15N resonances of the unbound FYVE domain were observed as the pH was varied (Fig. 1 C and F), and the patterns of crosspeak shifts did not match those of the bound state (Fig. 1 A and C). Furthermore, pH titration of the ligand-free FYVE domain yielded widespread inflection points, conceivably corresponding to the changes in protonation states of individual residues (Fig. 7B). Most of the inflection points were clustered in the pH range of 6.5–7.0, whereas that of His1371 was depressed at 6.0. Taken together, these data suggest that varying the pH alters the protonation state of the FYVE domain residues but does not by itself induce the significant chemical shift perturbations observed in the spectra of the ligand-bound protein. We conclude that the major effect of pH on the lipid-bound FYVE domain is the modulation of PtdIns(3)P interaction.

FYVE Domain Targeting to PtdIns(3)P-Containing Membranes Is pH-Dependent. To investigate whether pH dependence is preserved for PtdIns(3)P embedded in bilayers, liposome association of the FYVE domain was assayed. The FYVE domain was incubated with small unilamellar vesicles composed of lipids normally found in endosomal membranes including phosphatidylcholine (PtdCho), phosphatidylethanolamine (PtdEtn), phosphatidylserine (PtdSer), PtdIns, and PtdIns(3)P. After incubation at pH values of 5.5, 6.5, 7.5, or 8.0, partitioning of the FYVE domain between the supernatant and the pellet was examined by centrifugation. Only at pH 5.5 was most of the protein retained in the pelleted liposome fraction. At each progressively higher pH, the FYVE domain was increasingly distributed to the supernatant (Fig. 2 A and B). Such pH-dependent recruitment to bilayers is fully consistent with the pH dependency of PtdIns(3)P binding, with only 35–40% of the protein being active at pH 7.5, and redefines the FYVE domain as a pH sensor that targets PtdIns(3)P-containing bilayers.

Fig. 2.
pH-dependent membrane targeting by the FYVE domain. The SDS/PAGE gels (A) and histogram (B) show the partition of EEA1 FYVE, Vam7 PX, BSA, and GST between the supernatant (S) and PtdIns(3)P-enriched liposome pellet (P) at different pHs. The experimental ...

pH-Independent Recruitment of the Vam7 PX Domain. To establish whether the FYVE domain is unique in its pH sensitivity, we compared it with the only other module known to have canonical PtdIns(3)P-binding ability, the PX domain (20, 21). Unlike the FYVE domain, the Vam7 PX module localized to PtdIns(3)P-containing liposomes at all pH values tested (Fig. 2 A and B). This lack of pH-dependent targeting was supported by the absence of any significant chemical shift changes in the NMR spectra of Vam7 PX recorded at pH 6.0, 7.0, or 8.0 (Fig. 8, which is published as supporting information on the PNAS web site). Comparing the FYVE domain sequence with that of other phosphoinositide-binding proteins reveals that it is the only module with a conserved bis-histidine sequence (see below) or known pH sensitivity, suggesting a unique pH-dependent function.

Acidic Environment Enhances FYVE Domain Affinity. To determine the effect of the physiological pH range on the FYVE domain function, PtdIns(3)P binding was investigated at pH values of 6.0, 6.8, 7.4, and 8.0. The soluble C4-PtdIns(3)P lipid was gradually added to the FYVE domain at a constant pH, and 1H-15N HSQC spectra were recorded and superimposed (Figs. (Figs.3A3A and and1B).1B). Large progressive changes in the amide resonances of the FYVE domain were detected at pH 6.0 or 6.8, indicating a relatively strong interaction in the fast exchange regime on the NMR timescale. However, at pH 8, an excess of PtdIns(3)P induced barely any chemical shift perturbations, implying that ligand affinity is very weak under basic conditions (Figs. (Figs.3A3A and and1B1B).

Fig. 3.
Affinity for PtdIns(3)P increases in acidic media. (A) Superimposed 1H-15N HSQC spectra of the FYVE domain recorded during addition of PtdIns(3)P at pH values 6.0, 7.4, and 8.0. The relative concentrations of the 15N-labeled FYVE domain and PtdIns(3)P ...

Binding affinities were determined by analyzing changes in amide resonances of the FYVE domain. At pH 6.0, C4-PtdIns(3)P was bound by the FYVE domain with a Kd of 71 ± 2 μM (Fig. 3B). However, the same interaction was twice as weak at pH 6.8, 20 times weaker at pH 7.4, and 150 times weaker at pH 8.0, yielding affinities of 135 ± 9 μM, 1.3 ± 0.4 mM, and >10 mM, respectively (Fig. 3 C–E). The dependence of PtdIns(3)P affinity on pH is summarized in Fig. 3F, which shows a significant increase of FYVE activity in acidic environments, whereas under basic conditions, the protein becomes inactive.

The FYVE Domain Localizes to Endosomes at Low Cytosolic pH. To examine the role of intracellular pH in the targeting of FYVE domain in vivo, ECFP-fusion EEA1 FYVE was expressed in HeLa cells that were briefly incubated in media buffered to various pH values (Fig. 2C). Mammalian cells maintain an intracellular pH of ≈7.3 (23); however, cytosolic pH can be manipulated by changing the pH of the medium (24). After incubation of the ECFP-FYVE-expressing cells at pH 6.0, 6.5, 7.0, 7.5, 8.0, and 8.5, protein localization was examined by fluorescence microscopy. In media buffered to pH 6.0, ECFP-FYVE was strongly anchored to endosomal membranes (Fig. 2C). When the pH of the media was progressively increased, the ECFP signal of the membrane-associated FYVE domain was substantially diminished and a concomitant increase in the diffuse cytosolic ECFP-FYVE signal was observed. In basic conditions, ECFP-FYVE appeared completely released from the membranes. The most significant changes in FYVE domain localization occurred in the physiological pH range of 6.5–7.5. In contrast, the EGFP-p40phox PX domain was similarly bound to endosomal membranes at all pH values (Fig. 2D). Thus, the EEA1 FYVE domain localizes to endosomal compartments at low cytosolic pH, whereas at high pH values, the protein is dispersed in the cytosol.

To test the physiological relevance of pH sensing by the FYVE domain, the localization of ECFP-FYVE during apoptosis-induced cytosol acidification in HeLa cells was investigated. The cells were treated with the kinase inhibitor STS, which induces apoptosis and decreases cytosolic pH by 0.4 units (25). Although in the untreated cells the ECFP-FYVE domain was equally distributed between the cytosolic and endosome-bound fractions, STS treatment substantially shifted the equilibrium toward the membrane-bound state of the protein (Fig. 2F). These in vivo data corroborate the in vitro experiments and suggest that recruitment of the FYVE domain to membranes can be regulated by intracellular pH.

The Protonated State of a Histidine Switch Is Required for Interaction. The pH value of 7.4, where the free and PtdIns(3)P-bound states of the FYVE domain are in balance, is near the pKa range of His residues. The FYVE domain contains absolutely conserved His1371 and His1372 residues, which are located in the RRHHCR motif (Fig. 4A) and are intrinsically pH-sensitive (Fig. 1F). Another residue, His1340, is not conserved and is located in a 23-residue sequence N-terminal to the domain. Consequently, we investigated whether PtdIns(3)P binding is modulated by the protonation of these His residues.

Fig. 4.
Protonated His residues are required for the interactions. (A) A model of FYVE domain targeting to PtdIns(3)P-enriched membranes. The FYVE domain binds PtdIns(3)P, inserts its hydrophobic loop (MIL) into the membrane interior, and electrostatically contacts ...

The microscopic ionization constants of the three His residues of the FYVE domain were determined by NMR. The chemical shifts of imidazole's δ2H and ε1H in the ligand-free FYVE domain were monitored while the pH of the sample was varied. The pKa values of the His1340, His1371, and His1372 side chains were found to be 6.5, 5.9, and 6.5 ± 0.1, respectively (Fig. 4C). However, in the presence of the ligand, the pKa of both His1371 and His1372 increased to 7.4 ± 0.1, whereas the pKa of His1340, which is not a part of the FYVE domain, remained essentially unchanged at 6.3 (Fig. 4D). Thus, the new PtdIns(3)P recognition mechanism includes the protonation first of His1372 then of His1371, yielding two additional positive charges in the binding pocket. The active doubly protonated form of the FYVE domain predominates at pH values <5.9 in the absence of ligand or <7.4 when stabilized by bound ligand. These results, being in good agreement with the crystal and solution structures of the EEA1 FYVE domain (6, 13), also imply that the imidazole side chain of His1371 must be protonated to form a hydrogen bond to the 3-phosphate group of PtdIns(3)P (Fig. 4B). Similarly, protonated His1372 forms a pair of stabilizing hydrogen bonds to the 4- and 5-hydroxyl groups of PtdIns(3)P (Fig. 4B). Thus, we conclude that the successive dual protonation of His1372 and 1371 is required for coordination of the PtdIns(3)P headgroup by the FYVE domain.

The Presence of His1371 and His1372 Is Necessary for FYVE Domain Function. The critical role of His1371 and His1372 for PtdIns(3)P recognition was confirmed by mutagenesis. Substitution of these residues with Ala, Arg, Asn, Lys, or Tyr abolished PtdIns(3)P binding in vitro at any pH, as judged by NMR titrations (Fig. 9, which is published as supporting information on the PNAS web site). This indicates that both His residues are necessary for the interaction, and no residue with similar basic or aromatic character or hydrogen-bonding potential will suffice in either position. Furthermore, lowering the pH of the NMR samples of His1371 mutant proteins resulted in the collapse of the tertiary structure, whereas the fold of His1372 mutants was not disturbed (data not shown). Thus, although both conserved histidines are functionally essential, His1371, located in the center of the first β strand, is also required for protein structural stability.

To test whether His residues are necessary for the EEA1 targeting to endosomes, in vivo localization of ECFP- and EGFP-fusion FYVE proteins was examined by fluorescence microscopy. The wild-type fusion FYVE domain localized predominantly to endosomes in mammalian and yeast cells, whereas EGFP-fusion His1371Asn and His1372Asn mutant proteins were dispersed into the cytosol (Fig. 2E and Fig. 10, which is published as supporting information on the PNAS web site). These data reveal the importance of both histidine residues for the biological function of the FYVE domain.

Hydrophobic Insertion and PtdSer Interaction Are pH-Independent. Because the FYVE domain docking to membranes involves hydrophobic insertion into the bilayer (13) and nonspecific electrostatic contacts with acidic lipids (4), the effect of pH on these synergistic interactions was investigated (Fig. 11, which is published as supporting information on the PNAS web site). We found that the insertion of the PtdIns(3)P-bound FYVE domain into PtdSer-containing dodecyl phosphocholine (DPC) micelles was not pH-dependent, yielding similar affinities of 0.45 ± 0.05 and 0.44 ± 0.1 mM at pH values of 6.0 and 6.8. Nonspecific binding to PtdSer-containing DPC micelles in the absence of PtdIns(3)P was also pH-insensitive, based on a similar Kd of 7.3 ± 2 and 7.0 ± 1.4 mM at pH 6.0 and 6.8, respectively. However, pH dependency of PtdIns(3)P recognition was apparent for the micelle-associated state of the FYVE domain. That is, the affinities of the DPC-saturated FYVE domain for C4-PtdIns(3)P at pH 6 and 6.8 were estimated to be 15 ± 2 and 25 ± 3 μM, respectively. This 40% enhancement of binding was similar to the increase of the FYVE affinity for PtdIns(3)P in the absence of micelle systems.


Our results reveal that the EEA1 FYVE domain is recruited to PtdIns(3)P-enriched membranes in a pH-dependent manner. PtdIns(3)P is present in endosomal membranes at concentrations of ≈200 μM (26). Based on estimated affinities and the lipid's physiological concentrations, the FYVE domain exists in a mainly bound state in a low pH environment (pH 6.0–6.6). At the cytosolic pH level of 7.3, only half of the protein would be active, whereas essentially no activity would be detected in basic conditions. Thus, we predict that the FYVE domains exist in a balance between diffuse cytosolic and membrane-anchored populations and are sensitive to changes in both PtdIns(3)P concentrations and acidity within the cell.

pH dependence can influence the functions of FYVE proteins in cells with unusual cytosolic pH levels and in normal cells during physiological processes that involve changing of pH. Intracellular pH often fluctuates in response to cell growth, development, and apoptosis, with pH values ranging from 6.3 to 7.5 (2730), and varies in anomalous cells during ischemia (31), inflammation (32), and cancer (33). For example, cytosol acidification by as much as 0.8 pH units is associated with apoptosis (30), whereas several growth and survival factors induce alkalinization of cytosol by 0.25 pH units (34). Fluctuations of cytosolic pH in abnormal cells appear to be wider. Intracellular pH during ischemia drops to 6.2, whereas the cytosol of cancer cells is more basic than in normal cells (33). We found that the ECFP-EEA1 FYVE domain targeting to endosomal membranes is increased with the decrease in intracellular pH during STS-induced apoptosis, suggesting that partitioning of the FYVE domain can vary due to fluctuations in cellular acidification. Future research is required to further establish the significance of pH sensing by the FYVE domain and to test whether FYVE domain targeting is altered in other biological processes that are accompanied by changes in cytosolic pH.

A variety of cellular organelles and carrier vesicles including early endosomes maintain an acidic luminal pH (35). The V-type ATPase, the Cl channel, and the Na+/H+ exchanger form proton and ionic gradients maintaining the pH of early endosomes between 5.9 and 6.0 (Fig. 5). Regulation of luminal pH is essential for many intravesicular events and is also required for biological processes that occur in the cytoplasm. For example, localization of cytosolic ARNO (36), Arf6 (36), Arf1 (37), and COP coat proteins (38) to endosomal membranes depends on acidification of endosomes. The mechanism by which the low intra-endosomal pH controls properties of the proteins on the cytoplasmic surface of the vesicles remains unknown. It has been suggested that pH-dependent conformational changes in transmembrane proteins can transduce information across membranes (38). Another possible mechanism involves pH-dependent proton permeability and conductance of membranes (39) and a H+ leak pathway (40). Hydrogen ions leak through vesicular phospholipid bilayers at a very high rate, 10–5 cm/s (41, 42). Proton leakage forms a pH gradient across lipid bilayers, depressing the local pH on the cytoplasmic side of membranes.

Fig. 5.
Molecular mechanism of the EEA1 localization to early endosomes. EEA1 (consists of several indicated domains) is anchored to the endosomal membranes through the specific interaction of its FYVE domain (gray triangle) with PtdIns(3)P (purple), accompanied ...

The FYVE domains specifically target PtdIns(3)P-containing surfaces of low pH compartments, i.e., early endosomes, multive-sicular bodies, phagosomes, and Golgi (13, 8, 9). However, neutral or slightly alkaline organelles with significant PtdIns(3)P concentrations such as the nucleus or mitochondria do not recruit FYVE proteins (10, 23, 25). One possible explanation of these findings is in mediating the membrane targeting of the FYVE domain by the acidic luminal pH or local microenvironments and gradients. It remains to be determined whether this hypothesis is correct. Interestingly, EEA1 colocalizes with the endosomal Na+/H+ exchanger around which the formation of acidic microdomains has been proposed (43). In addition, reduced association of EEA1 to Mycobacterium tuberculosis-containing phagosomes, which are defective in luminal acidification, has recently been reported (44).


The data presented here reveal a pH-dependent mechanism of the EEA1 FYVE domain docking to PtdIns(3)P-enriched membranes. At the core of this mechanism is a histidine switch that, being activated by the acidic cellular environment, regulates membrane localization of the FYVE domain.

Supplementary Material

Supporting Information:


We thank M. Churchill, S. Emr, and A. Sorkin for discussions. This research was supported by grants from the National Institutes of Health (to C.B., V.V.V., M.O., and T.G.K.) and the American Cancer Society (to T.G.K.).


Author contributions: T.G.K. designed research; S.A.L., R.E., J.G., V.V.V., and C.B. performed research; S.A.L. and T.G.K. analyzed data; M.L.C. and M.O. contributed new reagents/analytic tools; and T.G.K. wrote the paper.

This paper was submitted directly (Track II) to the PNAS office.

Abbreviations: PtdIns(3)P, phosphatidylinositol 3-phosphate; EEA1, early endosome antigen 1; HSQC, heteronuclear single quantum coherence; PtdSer, phosphatidylserine; ECFP, enhanced cyan fluorescent protein; STS, staurosporin.


1. Gaullier, J. M., Simonsen, A., D'Arrigo, A., Bremnes, B., Stenmark, H. & Aasland, R. (1998) Nature 394, 432–433. [PubMed]
2. Patki, V., Lawe, D. C., Corvera, S., Virbasius, J. V. & Chawla, A. (1998) Nature 394, 433–434. [PubMed]
3. Burd, C. G. & Emr, S. D. (1998) Mol. Cell 2, 157–162. [PubMed]
4. Kutateladze, T. G., Capelluto, D. G. S., Ferguson, C. G., Cheever, M. L., Kutateladze, A. G., Prestwich, G. D. & Overduin, M. (2004) J. Biol. Chem. 279, 3050–3057. [PubMed]
5. Diraviyam, K., Stahelin, R. V., Cho, W. & Murray, D. (2003) J. Mol. Biol. 328, 721–736. [PubMed]
6. Dumas, J. J., Merithew, E., Sudharshan, E., Rajamani, D., Hayes, S., Lawe, D., Corvera, S. & Lambright, D. (2001) Mol. Cell 8, 947–958. [PubMed]
7. Kutateladze, T. G., Ogburn, K. D., Watson, W. T., de Beer, T., Emr, S. D., Burd, C. G. & Overduin, M. (1999) Mol. Cell 3, 805–811. [PubMed]
8. Derubeis, A. R., Young, M. F., Jia, L., Robey, P. G. & Fisher, L. W. (2000) Gene 255, 195–203. [PubMed]
9. Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L. & Wrana, J. L. (1998) Cell 95, 779–791. [PubMed]
10. Gillooly, D. J., Morrow, I. C., Lindsay, M., Gould, R., Bryant, N. J., Gaullier, J. M., Parton, R. G. & Stenmark, H. (2000) EMBO J. 19, 4577–4588. [PMC free article] [PubMed]
11. Gaullier, J. M., Ronning, E., Gillooly, D. J. & Stenmark, H. (2000) J. Biol. Chem. 275, 24595–24600. [PubMed]
12. Lawe, D. C., Patki, V., Heller-Harrison, R., Lambright, D. & Corvera, S. (2000) J. Biol. Chem. 275, 3699–3705. [PubMed]
13. Kutateladze, T. G. & Overduin, M. (2001) Science 291, 1793–1796. [PubMed]
14. Sankaran, V. G., Klein, D. E., Sachdeva, M. M. & Lemmon, M. A. (2001) Biochemistry 40, 8581–8587. [PubMed]
15. Sbrissa, D., Ikonomov, O. C. & Shisheva, A. (2002) J. Biol. Chem. 277, 6073–6079. [PubMed]
16. Stahelin, R. V., Long, F., Diraviyam, K., Bruzik, K. S., Murray, D. & Cho, W. (2002) J. Biol. Chem. 277, 26379–26388. [PubMed]
17. Mao, Y., Nickitenko, A., Duan, X., Lloyd, T. E., Wu, M. N., Bellen, H. & Quiocho, F. A. (2000) Cell 100, 447–456. [PubMed]
18. Misra, S. & Hurley, J. H. (1999) Cell 97, 657–666. [PubMed]
19. Grzesiek, S., Stahl, S. J., Wingfield, P. T. & Bax, A. (1996) Biochemistry 35, 10256–10261. [PubMed]
20. Cheever, M. L., Sato, T. K., de Beer, T., Kutateladze, T. G., Emr, S. D. & Overduin, M. (2001) Nat. Cell. Biol. 3, 613–618. [PubMed]
21. Yu, J. W. & Lemmon, M. A. (2001) J. Biol. Chem. 276, 44179–44184. [PubMed]
22. Patki, V., Virbasius, J., Lane, W. S., Toh, B. H., Shpetner, H. S. & Corvera, S. (1997) Proc. Natl. Acad. Sci. USA 94, 7326–7330. [PMC free article] [PubMed]
23. Llopis, J., McCaffery, J. M., Miyawaki, A., Farquhar, M. G. & Tsien, R. Y. (1998) Proc. Natl. Acad. Sci. USA 95, 6803–6808. [PMC free article] [PubMed]
24. Brett, C. L., Tukaye, D. N., Mukherjee, S. & Rao, R. (2005) Mol. Biol. Cell 16, 1396–1405. [PMC free article] [PubMed]
25. Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y. & Reed, J. C. (2000) Nat. Cell. Biol. 2, 318–325. [PubMed]
26. Stenmark, H. & Gillooly, D. J. (2001) Cell. Dev. Biol. 12, 193–199. [PubMed]
27. Gottlieb, R. A., Giesing, H. A., Zhu, J. Y., Engler, R. L. & Babior, B. M. (1995) Proc. Natl. Acad. Sci. USA 92, 5965–5968. [PMC free article] [PubMed]
28. Moolenaar, W. H., Tsien, R. Y., van der Saag, P. T. & de Laat, S. W. (1983) Nature 304, 645–648. [PubMed]
29. Schuldiner, S. & Rozengurt, E. (1982) Proc. Natl. Acad. Sci. USA 79, 7778–7782. [PMC free article] [PubMed]
30. Thangaraju, M., Sharma, K., Leber, B., Andrews, D. W., Shen, S. H. & Srikant, C. B. (1999) J. Biol. Chem. 274, 29549–29557. [PubMed]
31. LaManna, J. C. (1996) Adv. Exp. Med. Biol. 388, 283–292. [PubMed]
32. Punnia-Moorthy, A. (1987) J. Oral Pathol. 16, 36–44. [PubMed]
33. Gerweck, L. E. & Seetharaman, K. (1996) Cancer Res. 56, 1194–1198. [PubMed]
34. Rajotte, D., Haddad, P., Haman, A., Cragoe, E. J., Jr. & Hoang, T. (1992) J. Biol. Chem. 267, 9980–9987. [PubMed]
35. Marshansky, V. & Vinay, P. (1996) Biochim. Biophys. Acta 1284, 171–180. [PubMed]
36. Maranda, B., Brown, D., Bourgoin, S., Casanova, J. E., Vinay, P., Ausiello, D. A. & Marshansky, V. (2001) J. Biol. Chem. 276, 18540–18550. [PubMed]
37. Zeuzem, S., Feick, P., Zimmermann, P., Haase, W., Kahn, R. A. & Schulz, I. (1992) Proc. Natl. Acad. Sci. USA 89, 6619–6623. [PMC free article] [PubMed]
38. Gu, F. & Gruenberg, J. (2000) J. Biol. Chem. 275, 8154–8160. [PubMed]
39. Miedema, H., Staal, M. & Prins, H. B. A. (1996) J. Membr. Biol. 152, 159–167. [PubMed]
40. Wu, M. M., Grabe, M., Adams, S., Tsien, R. Y., Moore, H. P. & Machen, T. E. (2001) J. Biol. Chem. 276, 33027–33035. [PubMed]
41. Haines, T. H. (2001) Prog. Lipid Res. 40, 299–324. [PubMed]
42. Nichols, J. W. & Deamer, D. W. (1980) Proc. Natl. Acad. Sci. USA 77, 2038–2042. [PMC free article] [PubMed]
43. Akhter, S., Kovbasnjuk, O., Li, X., Cavet, M., Noel, J., Arpin, M., Hubbard, A. L. & Donowitz, M. (2002) Am. J. Physiol. Cell. Physiol. 283, C927–C040. [PubMed]
44. Fratti, R. A., Chua, J. & Deretic, V. (2003) J. Biol. Chem. 278, 46961–46967. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...